Total Payments
$145,852
2024 Payments
$33,682
Companies
3
Transactions
61
Medicare Patients
1,311
Medicare Billing
$127,018
Payment Breakdown by Category
Consulting$145,819 (100.0%)
Food & Beverage$33.50 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $145,819 | 60 | 100.0% |
| Food and Beverage | $33.50 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $145,344 | 59 | $0 (2024) |
| Shire North American Group Inc | $475.00 | 1 | $0 (2019) |
| Exact Sciences Corporation | $33.50 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $33,682 | 13 | Takeda Pharmaceuticals U.S.A., Inc. ($33,648) |
| 2023 | $37,555 | 13 | Takeda Pharmaceuticals U.S.A., Inc. ($37,555) |
| 2022 | $25,584 | 10 | Takeda Pharmaceuticals U.S.A., Inc. ($25,584) |
| 2021 | $32,356 | 17 | Takeda Pharmaceuticals U.S.A., Inc. ($32,356) |
| 2020 | $16,200 | 7 | Takeda Pharmaceuticals U.S.A., Inc. ($16,200) |
| 2019 | $475.00 | 1 | Shire North American Group Inc ($475.00) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,588.32 | General |
| 11/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,235.40 | General |
| 10/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,941.24 | General |
| 09/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,235.40 | General |
| 09/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,235.40 | General |
| 08/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,588.32 | General |
| 08/13/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $33.50 | General |
| Category: Oncology | ||||||
| 07/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,235.40 | General |
| 05/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,235.40 | General |
| 05/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,588.32 | General |
| 03/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,941.24 | General |
| 03/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,235.40 | General |
| 02/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,588.32 | General |
| 12/20/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,235.40 | General |
| 11/17/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,496.00 | General |
| 10/16/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,496.00 | General |
| 09/18/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,120.00 | General |
| 09/08/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,496.00 | General |
| 08/21/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,496.00 | General |
| 07/12/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,120.00 | General |
| 07/05/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,120.00 | General |
| 05/19/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,496.00 | General |
| 05/12/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,120.00 | General |
| 03/24/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,120.00 | General |
| 01/13/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,120.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 339 | 461 | $101,859 | $33,935 |
| 2022 | 6 | 332 | 419 | $83,434 | $30,033 |
| 2021 | 7 | 348 | 456 | $94,635 | $37,727 |
| 2020 | 5 | 292 | 380 | $81,084 | $25,322 |
Total Patients
1,311
Total Services
1,716
Medicare Billing
$127,018
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 167 | 274 | $53,560 | $16,323 | 30.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 118 | 118 | $37,645 | $14,864 | 39.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $4,798 | $1,764 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 18 | $2,576 | $766.93 | 29.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 25 | 40 | $3,280 | $216.32 | 6.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 144 | 222 | $40,789 | $13,460 | 33.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 104 | 104 | $30,240 | $13,424 | 44.4% |
| 77067 | Screening mammography | Office | 2022 | 15 | 15 | $4,815 | $1,406 | 29.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 31 | $4,021 | $1,171 | 29.1% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 15 | 15 | $1,005 | $357.30 | 35.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 25 | 32 | $2,564 | $215.75 | 8.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 117 | 117 | $33,065 | $15,387 | 46.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 142 | 225 | $39,159 | $15,020 | 38.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 18 | 35 | $7,420 | $1,957 | 26.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 36 | $4,306 | $1,654 | 38.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 16 | $3,584 | $1,507 | 42.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 15 | $3,885 | $1,206 | 31.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 12 | 12 | $3,216 | $996.84 | 31.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 99 | 99 | $27,720 | $11,418 | 41.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 136 | 218 | $41,494 | $10,899 | 26.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 16 | 16 | $3,606 | $1,228 | 34.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 27 | 32 | $4,169 | $1,013 | 24.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 14 | 15 | $4,095 | $763.38 | 18.6% |
About Dr. Taylor Mertz, MD
Dr. Taylor Mertz, MD is a Family Medicine healthcare provider based in Moorhead, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2011. The National Provider Identifier (NPI) number assigned to this provider is 1285926360.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Taylor Mertz, MD has received a total of $145,852 in payments from pharmaceutical and medical device companies, with $33,682 received in 2024. These payments were reported across 61 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($145,819).
As a Medicare-enrolled provider, Mertz has provided services to 1,311 Medicare beneficiaries, totaling 1,716 services with total Medicare billing of $127,018. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Moorhead, MN
- Active Since 05/09/2011
- Last Updated 12/24/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1285926360
Products in Payments
- Cologuard Collection Kit (Device) $33.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Moorhead
Dr. Allan Luistro, M.d, M.D
Family Medicine — Payments: $5,090
Family Medicine $5,090
Dr. Rodney Lee, Md, MD
Family Medicine — Payments: $13.53
Family Medicine $13.53
Emil Steinke, Md, MD
Family Medicine
Family Medicine
Jerry Rogers, Md, MD
Family Medicine
Family Medicine
Robert Campbell, Md, MD
Family Medicine
Family Medicine
Steven Glunberg, Md, MD
Family Medicine
Family Medicine